StockNews.com started coverage on shares of LiqTech International (NASDAQ:LIQT – Free Report) in a report issued on Thursday morning. The brokerage issued a sell rating on the stock.
LIQT has been the subject of several other reports. Lake Street Capital decreased their target price on shares of LiqTech International from $9.00 to $6.00 and set a “buy” rating for the company in a research note on Thursday, October 10th. Ascendiant Capital Markets reaffirmed a “buy” rating and issued a $5.15 target price on shares of LiqTech International in a report on Monday, August 26th.
Read Our Latest Stock Analysis on LIQT
LiqTech International Price Performance
Institutional Investors Weigh In On LiqTech International
A hedge fund recently raised its stake in LiqTech International stock. HighTower Advisors LLC lifted its position in shares of LiqTech International, Inc. (NASDAQ:LIQT – Free Report) by 40.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 38,599 shares of the company’s stock after purchasing an additional 11,043 shares during the period. HighTower Advisors LLC owned 0.66% of LiqTech International worth $99,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 35.06% of the company’s stock.
About LiqTech International
LiqTech International, Inc, a clean technology company, designs, develops, produces, markets, and sells automated filtering systems, ceramic silicon carbide liquid applications, and diesel particulate air filters in the United States, Canada, Europe, Asia, and South America. The company operates through Water, Ceramics, and Plastics segments.
Recommended Stories
- Five stocks we like better than LiqTech International
- What is a Bond Market Holiday? How to Invest and Trade
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What Are Dividend Achievers? An Introduction
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What is the NASDAQ Stock Exchange?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for LiqTech International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiqTech International and related companies with MarketBeat.com's FREE daily email newsletter.